Poly is more Effective than Mono - Unsaturated Fat For dietary management IN the Metabolic Syndrome: The MUFFIN Study

AlphaZance

Abstract
Background
The Metabolic Syndrome (MetS) is highly prevalent and associated with an increased risk for Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Lifestyle recommendations to treat MetS often include the replacement of saturated fats (SFA) and monosacharides with unsaturated fat. However, it is unclear whether metabolic parameters will improve more when the saturated fat in American Heart Association (AHA) diets is replaced with higher concentrations of mono or poly-unsaturated fatty acids (MUFA, PUFA).

Objective
To test the hypothesis that an AHA diet enriched in MUFA improves lipoprotein lipids, insulin resistance, inflammation and endothelial function to a greater extent than a diet enriched in PUFA in middle-aged men and women with MetS.

Methods
A prospective, open-label, parallel group design with randomization to a hypocaloric MUFA or PUFA enriched diet following weight stabilization on an AHA Step I diet. Participants consumed 3 MUFA or PUFA enriched muffins daily with additional supplementation as required to ensure 25-50% increases in dietary fat intake from these sources at the expense of SFA and the opposing unsaturated fat. Changes in MetS components were measured at baseline and after 6 months of dietary intervention.

Results
Thirty-nine participants (mean age 60.8 years, 79% African-American, 60% women) with MetS completed the 6-month study. Compared to baseline, assignment to either MUFA (n=23) or PUFA (n=16) both were associated with weight loss (WL) (MUFA: −2.3±1 kg, P=0.06; PUFA: −4.6±2 kg; P=0.002), but PUFA was also associated with reductions in triglycerides (TG) (−30±18 mg/dL, P=0.02), systolic blood pressure (BP) (−7±3 mmHg, P=0.01), diastolic BP (DBP) (−4±2 mmHg, P=0.01) and improved flow mediated dilation (FMD) (7.1±1.8% vs. 13.6±2%, absolute increase; P=0.0001). When compared to MUFA treatment, PUFA intervention was associated with reduced TG (P=0.04) and DBP (P=0.07) as well as increased FMD (P=0.04) even after adjustment for changes in weight. There was no effect on total cholesterol, low-density lipoprotein cholesterol (LDL-C), glucose, high-sensitivity C-reactive protein (hs-CRP) or other inflammatory proteins. Overall, 25% (4 of 16) assigned to PUFA and 13% (3 of 23) to MUFA converted to non-MetS status.

Conclusion
Substitution of SFA with PUFA in patients with MetS is associated with greater reductions in TG and improvement in endothelial function than MUFA that is independent of WL. These preliminary findings raise the possibility that PUFA may be the unsaturated fat of choice to reduce cardiometabolic risk in patients with MetS.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5010036/

The conflict you’ve highlighted is the central battleground between Bioenergetic (Ray Peat) principles and Mainstream Lipid Science.

To understand why a study like the MUFFIN study shows positive results for Polyunsaturated Fats (PUFA) while Ray Peat viewed them as metabolic toxins, we have to look at the different metrics they prioritize: short-term blood markers versus long-term cellular stability.

1. The Chemical Difference: Why Peat Opposed PUFA

Ray Peat’s primary argument against PUFAs (like those found in soybean, corn, and sunflower oils) was based on their chemical structure. PUFAs have multiple "double bonds."

Saturated Fats (SFA): Have no double bonds. They are straight, stable, and resistant to heat and oxygen.
Polyunsaturated Fats (PUFA): Have multiple double bonds. These bonds are "open" sites where oxygen can attack, leading to lipid peroxidation.

According to Peat, when these unstable fats are incorporated into human tissues (cell membranes and mitochondria), they make the body more susceptible to oxidative stress, inhibit thyroid function, and promote the formation of age pigments (lipofuscin).

2. Analyzing the MUFFIN Study through a "Peat" Lens

The MUFFIN study found that PUFAs were superior to Monounsaturated Fats (MUFA) for improving triglycerides and blood pressure in patients with Metabolic Syndrome. A follower of Ray Peat would likely critique these findings using the following arguments:

A. The Weight Loss Confounding Factor

In the study, the PUFA group lost significantly more weight (-4.6 kg) than the MUFA group (-2.3 kg).

The Mainstream View: PUFAs might improve insulin sensitivity, leading to better weight loss.
The Peat View: PUFAs are known to be "pro-metabolic" only in the sense that they can be toxic to the mitochondria, sometimes causing a "wasting" effect or a stress-induced increase in metabolic rate. Peat often argued that PUFAs interfere with the body's ability to store energy efficiently, which might show up as weight loss but at the cost of increased systemic stress.

B. The "Blood Clearing" Effect vs. Tissue Accumulation

The study focuses on Triglycerides (TG) and Flow Mediated Dilation (FMD).

The Mainstream View: Lowering triglycerides in the blood is a sign of improved cardiovascular health.
The Peat View: PUFAs lower blood lipids because they are easily oxidized and "pulled" out of the blood into the tissues, or because they inhibit the liver's ability to release glucose and fats. Peat argued that having lower fats in the blood isn't a benefit if those fats are being stored in your cell membranes, where they remain vulnerable to turning into toxic byproducts like acrolein and 4-HNE.

C. The Randle Cycle (Glucose Competition)

Ray Peat’s work heavily emphasized the Randle Cycle, a metabolic process where the oxidation of fats inhibits the oxidation of glucose.

Peat argued that PUFAs are particularly effective at blocking the "burning" of sugar. While the MUFFIN study suggests improved "metabolic management," Peat would argue that over the long term, high PUFA intake forces the body into a state of "fat-burning" that mimics diabetes at a cellular level, suppressing the more efficient oxidative metabolism of glucose.

3. Why the results differ

The MUFFIN study and Ray Peat are essentially looking at two different things:

Feature	Mainstream/MUFFIN Study Focus	Ray Peat/Bioenergetic Focus
Primary Goal	Lowering blood markers (TG, BP, LDL).	Increasing metabolic rate and CO2 production.
Timeframe	Short-term (6 months).	Decades of tissue accumulation.
Mechanism	PUFAs as "essential" signaling molecules.	PUFAs as "anti-thyroid" and oxidative toxins.
Endothelial Health	Measured via blood flow (FMD).	Measured via resistance to lipid peroxidation.

Summary

The MUFFIN study provides evidence that for obese individuals with metabolic syndrome, replacing saturated fats with PUFA can lead to rapid improvements in clinical biomarkers (blood pressure and triglycerides).

Ray Peat would counter that these improvements are superficial. He would argue that the participants are trading "good-looking" blood tests for long-term "rotten" cellular membranes. From a Peat perspective, the "metabolic syndrome" is caused by a lack of sugar oxidation, and adding PUFAs—even if they lower blood pressure in the short term—further suppresses the thyroid and the body's ability to use oxygen properly.

yerrag

@AlphaZance

Very nicely presented.

Viewing the same data but interpreting from different lenses. First, mainstream short term vs. Ray Peat long term. Secondly, mainstream blood level vs. Ray Peat tissue level.

I have this kind of experience using my Ray Peat perspective when I use Deepseek AI. I ask a normal health related question like a newbie would. I would get a typical run-of-the-mill mainstream medical response.

Then I push back explaining why I differ using my RP hat.
Deepseek would reconsider and reframe after I reason out. And I would get a more Peaty response.

I can share one session I had with Deepseek to givevan example. Just let me know if you or anyone here is interested.

LucH

@AlphaZance said in Poly is more Effective than Mono - Unsaturated Fat For dietary management IN the Metabolic Syndrome: The MUFFIN Study:

The MUFFIN study provides evidence that for obese individuals with metabolic syndrome, replacing saturated fats with PUFA can lead to rapid improvements in clinical biomarkers (blood pressure and triglycerides).

Hi,
I see a bias in this 6 months study:
They're under control; so they eat differently, taking insulinoma into account, with a limiting amount of food. And yes if you were eating an unbalanced diet, different from 45 45 10 % , you're going to get problems. And a correlation between improved blood markers and muffins with safflower (rich in PUFA) is a kind of misfit when you conclude with "RP anti-theory on PUFAs", compared to "Pufa's are essential". Everyody agrees to says omega-3 have a calming effect, namely against inflammation and savage growth (cancer), except this effect is only a short-term effect. There are side-effects (...). The tree hides the forest.

LucH

If you want other sources:
Are PUFAs toxic?
Video of Chris Masterjohn 30’
https://youtu.be/WRmUzYD8l7Q
CM earned a PhD in Nutritional Sciences from the University of Connecticut in 2012 and currently researches the physiological interactions between fat-soluble vitamins A, D, and K at the University of Illinois, Urbana-Champaign.

https://chriskresser.com/an-update-on-omega-6-pufas/

Eat real food and balance your diet.
Avoid industrial seed oils.
Don’t go overboard with the nut flours.
Eat pre-formed EPA and DHA (white fish).

Ray Peat PhD. – Kate Deering – Dr. Rita Lee – Etc.
Huile de poisson et effet sur la thyroïde
http://mirzoune-ciboulette.forumactif.org/t1388-huile-de-poisson-et-effet-sur-la-thyroide#15791
Effets anti thyroïde des oméga-3 (In French, translator needed) (See translation of the excerpt below)
Excerpt:
Translation (« Huile de poisson et effet sur la thyroïde » => Fish oil and effect on thyroid)
• ALA administration results in a 22% reduction in T3, the most potent form of thyroid hormone. T4 to T3 conversion rates decrease by 56% in response to ALA ingestion. ALA even interferes with normal T3 levels if you pre-administer T4 into the cells. (2)
2. http://www.ncbi.nlm.nih.gov/pubmed/1815532
• Animals fed a high PUFA diet compared to a high SFA diet (with corn oil or lard) experienced a significant decrease in thyroid hormone response in PUFA-fed rats. (3)
http://www.jbc.org/content/256/14/7113.full.pdf+html

Excerpt 1 from: Arachidonic acid causes an uncoupling effect and inhibits cellular respiration
https://www.sciencedirect.com/science/article/pii/S0891584999000349
“It is shown that arachidonic acid causes an uncoupling effect under state 4 respiration of intact mitochondria as well as a marked inhibition of uncoupled respiration.

Excerpt 2 from: Unsaturated Vegetable Oils: Toxic
http://www.raypeat.com/articles/articles/unsaturated-oils.shtml

To defend the seeds from the animals that would eat them, the [PUFA]-oils block the digestive enzymes in the animals' stomachs.
Their tendency to oxidize is very great. These oxidative processes can damage enzymes and other parts of cells, and especially their ability to produce energy.
The enzymes which break down proteins are inhibited by unsaturated fats, and these enzymes are needed not only for digestion, but also for production of thyroid hormones, clot removal, immunity, and the general adaptability of cells. The risks of abnormal blood clotting, inflammation, immune deficiency, shock, aging, obesity, and cancer are increased. Thyroid and progesterone are decreased. Since the unsaturated oils block protein digestion in the stomach, we can be malnourished even while "eating well."

*) Useful info: more to be read on my forum.
Effets anti-thyroïde des oméga-3
Effets Immunosuppressifs des omega-3
https://mirzoune-ciboulette.forumactif.org/t2042-effets-anti-thyroide-des-omega-3#29683
Excerpt:
No one disputes the benefits of omega-3s for reducing inflammation and counteracting an overactive immune response. But it's all about long-term use. Not to mention that some sources of omega-3s also provide omega-6s. This leads to the storage and release of amino acids. See the details in the post "Fatty Acids for Dummies," linked below. (15) You'll find further information in the links provided below.